Loading...

The current price of BGM is 5.99 USD — it has increased 10.31 % in the last trading day.
BGM Group Ltd, formerly Qilian International Holding Group Ltd, is a company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The Company's main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.
Wall Street analysts forecast BGM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BGM is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
BGM Group Ltd revenue for the last quarter amounts to NaN USD, decreased % YoY.
BGM Group Ltd. EPS for the last quarter amounts to USD, decreased % YoY.
BGM Group Ltd (BGM) has 323 emplpoyees as of December 15 2025.
Today BGM has the market capitalization of 1.09B USD.